Our Company
 |
Technology solutions that shape the future are those with the greatest potential to improve the way we live and work and the greatest potential for commercial success. Large companies rarely conceive these technologies. Rather, they are more often the product of visionary inventors or small companies working intensely, with a strong sense of purpose, dedication and cooperation people who want to make a difference in the world through their work. Manhattan Scientifics, Inc. (MHTX) advances technologies with potential world-changing impact to the threshold of commercialization by following these principles of purpose, dedication and cooperation. With highly skilled scientific and engineering expertise, resourceful, experienced management, and strategic alliances Manhattan Scientifics is working to bring technology solutions that shape the future into the commercial marketplace today.
Our News
July 27, 2010
Beyond Flip-Of-A-Coin Breast Cancer Diagnosis
An article last week in The New York Times, "Prone to Error: Earliest Steps to Find Cancer," stated some disturbing facts about the detection--and misdiagnosis--of an early form of breast cancer called ductal carcinoma in situ (DCIS). According to the piece, a study by the breast cancer survivors' organization, Susan G. Komen for the Cure, estimated that in 90,000 cases, women who receive a diagnosis of DCIS either did not have the disease or their pathologist made an error that resulted in incorrect treatment. Worst of all, prominent experts went on the record in characterizing the diagnosis of certain breast lesions as a "flip of a coin."
July 26, 2010
Manhattan Scientifics Promoting a New Technology to Eliminate False Positive Cancer Analysis
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics, Inc. (OTCBB: MHTX) said today that a July 20th New York Times article titled "Prone to Error: Earliest Steps to Find Cancer" highlights the potential value of the early cancer detection technology developed by Senior Scientific, LLC and licensed by Manhattan Scientifics.
July 8, 2010
Manhattan Scientifics Announces the Initiation of a Joint Project to Create Biological Metals for Medical Implants
LOS ALAMOS, N.M.--(BUSINESS WIRE)--The Australian government announced that Manhattan Scientifics (OTCBB:MHTX) and its existing industrial partner, Carpenter Technology Corporation (NYSE:CRS) have joined with a new industrial partner, Cochlear Ltd. (ASX:COH) to create customized metals for use in human beings advancing the bionic age. "We're living longer and we need new parts," said Marvin Maslow, Founder Manhattan Scientifics.
June 24, 2010
Dr. Ed Flynn's Technology Featured in Center for Integrated Nanotechnologies (CINT) Annual Report
Dr. Edward Flynn, founder and president of Senior Scientific,LLC, has developed a nanotechnology-based, magnetic imaging method for early diagnosis and treatment of cancer that could provide a significant increase in detection sensitivity; much earlier detection of certain cancers; more targeted therapies; and potentially better treatment outcomes.
April 21, 2010
Manhattan Scientifics' Technology Able to Detect Breast Cancer Three Years Earlier Than Mammogram
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics, Inc. (OTCBB: MHTX) announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test.
Technology
 |
Advanced MaterialsManhattan Scientifics has acquired the exclusive rights to the key patents and IP and will soon be positioned to enter into manufacturing and licensing agreements. |
|
 |
NanomedicineManhattan Scientifics and Senior Scientific, LLC have announced that they have begun cooperative work to commercialize Senior ScientificÕs nano medicine cancer detection technology. |
|
Dr. Ed Flynn's Technology Featured in Center for Integrated Nanotechnologies (CINT) Annual Report Dr. Edward Flynn, founder and president of Senior Scientific, LLC, has developed a nanotechnology-based, magnetic imaging method for early diagnosis and treatment of cancer that could provide a significant increase in detection sensitivity. Photographer |
||
Manhattan Scientifics Inc. © 2008 - 2010 | Code of Ethics | Disclaimer
